It’s great to see another excellent endovascular treatment option added to the armamentarium for managing aortic arch pathology.
Congratulations to Endospan and the entire team on a well-conducted trial and achieving FDA approval. This is an important step forward in expanding endovascular solutions for the complex aortic disease.
@TheAortologist @carlos____camps
Congratulations to Endospan and the entire team on a well-conducted trial and achieving FDA approval. This is an important step forward in expanding endovascular solutions for the complex aortic disease.
@TheAortologist @carlos____camps
We are proud to announce a major milestone in our mission to deliver a minimally invasive alternative for aortic care. The FDA has approved the NEXUS Aortic Arch Stent Graft for treatment of the ascending aorta and arch in chronic dissection patients who are at high risk for open surgical repair.View quoted post on X
You can read the full press release and learn more here: tinyurl.com/4dksye7k
#NEXUSaorta #totalarch #aorticdissection #aorticarchrepair #aortaEd
Essential Prescribing Information: tinyurl.com/594ntx44